At the time of writing, Gilead Sciences, Inc [GILD] stock is trading at $111.03, up 0.98%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GILD shares have gain 6.68% over the last week, with a monthly amount glided 19.49%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Gilead Sciences, Inc [NASDAQ: GILD] stock has seen the most recent analyst activity on February 18, 2025, when Deutsche Bank upgraded its rating to a Buy but kept the price target unchanged to $120 for it. Previously, DZ Bank upgraded its rating to Buy on February 13, 2025, and kept the price target unchanged to $108. On January 10, 2025, upgrade upgraded it’s rating to Overweight and revised its price target to $113 on the stock. Wolfe Research initiated its recommendation with a Outperform and recommended $110 as its price target on November 15, 2024. Citigroup started tracking with a Buy rating for this stock on November 14, 2024, and assigned it a price target of $125. In a note dated November 08, 2024, Maxim Group downgraded an Hold rating on this stock.
For the past year, the stock price of Gilead Sciences, Inc fluctuated between $62.07 and $111.03. Currently, Wall Street analysts expect the stock to reach $89.71 within the next 12 months. Gilead Sciences, Inc [NASDAQ: GILD] shares were valued at $111.03 at the most recent close of the market. An investor can expect a potential drop of -19.2% based on the average GILD price forecast.
Analyzing the GILD fundamentals
According to Gilead Sciences, Inc [NASDAQ:GILD], the company’s sales were 28.73B for trailing twelve months, which represents an 6.50% jump. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.04 and Total Capital is 0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 109.66 points at the first support level, and at 108.28 for the second support level. However, for the 1st resistance point, the stock is sitting at 112.20, and for the 2nd resistance point, it is at 113.36.
Ratios To Look Out For
It is important to note that Gilead Sciences, Inc [NASDAQ:GILD] has a current ratio of 1.50. In addition, the Quick Ratio stands at 1.20. Considering the valuation of this stock, the price to sales ratio is 4.82, the price to book ratio is 7.19 and price to earnings (TTM) ratio is 299.35.
Transactions by insiders
Recent insider trading involved GILEAD SCIENCES, INC., 10% Owner, that happened on Feb 18 ’25 when 1.36 million shares were purchased. Chief Financial Officer, Dickinson Andrew D completed a deal on Feb 18 ’25 to sell 2500.0 shares. Meanwhile, Officer ANDREW DICKINSON bought 2500.0 shares on Feb 18 ’25.
